News - 2019
Check out the posts below to learn the latest updates on our progress
- June 18 2019EXUMA Biotechnology Expands Leadership Team with Appointment of Chief Medical Officer and Chief Financial OfficerPRNewswire
- May 21 2019Shanghai Perhum Therapeutics Announces Preliminary Results Of Two First-in-Human Solid Tumor CAR-T ProductsPRNewswire
- April 3 2019Same Day Transduction and In Vivo Expansion of a Chimeric Antigen Receptor with a Synthetic Driver Construct for Adoptive Cellular TherapyAACR 2019
- April 3 2019A High-Throughput Screening Strategy for the Identification of Novel Lymphoproliferative ElementsAACR 2019
- April 3 2019CAB-CAR-T: The Prioritization of Cell Surface Protein Targets for Conditionally Active Biologics to Treat All Solid TumorsAACR 2019
- April 3 2019A Novel Conditionally Active Biologics Approach to Minimize On-target Off-tumor Effects in Adoptive ImmunotherapyAACR 2019
- March 31 2019F1 Oncology to Present Data That Expands on Proof of Novel Point of Care Approach for CAR-T Therapies in Solid Tumor MalignanciesBusiness Wire
- March 29 2019Taking the Next Step: What We’ve Learned About CAR-T So Far, and What It Means Going Forward
- January 6 2019Cancer Doesn’t See Borders – And Neither Should Biotech